Drug Designing: Open Access

Drug Designing: Open Access
Open Access

ISSN: 2169-0138

The importance of pharmacovigilance


JOINT EVENT ON 3rd International Conference and Expo on DRUG DISCOVERY & DESIGNING and 9th Annual PHARMACEUTICAL CHEMICAL ANALYSIS CONGRESS

October 02-03, 2017 | Vienna, Austria

Rucha Majmundar Mehta

R Q Consultants, India

Scientific Tracks Abstracts: Drug Des

Abstract :

Safety monitoring of medicinal products: 1. Drug monitoring 2. Pharmaceutical preparations - adverse effects 3. Adverse drug reaction reporting 4. Product surveillance, Postmarketing 5. Legislation, Drug The purpose of pharmacovigilance: Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other possible drug-related problems. Recently, its concerns have been widened to include: ΓΆΒ?ΒΆ Herbals ΓΆΒ?ΒΆ Traditional and Complementary Medicines ΓΆΒ?ΒΆ Blood Products ΓΆΒ?ΒΆ Biologicals ΓΆΒ?ΒΆ Medical Devices & Vaccines The specific aims of pharmacovigilance are to: ΓΆΒ?ΒΆ Improve patient care and safety in relation to the use of medicines and all medical and paramedical interventions, ΓΆΒ?ΒΆ Improve public health and safety in relation to the use of medicines ΓΆΒ?ΒΆ Contribute to the assessment of benefit, harm, effectiveness and risk of medicines, encouraging their safe, rational and more effective (including cost-effective) use, and ΓΆΒ?ΒΆ Promote understanding, education and clinical training in pharmacovigilance and its effective communication to the public ΓΆΒ?ΒΆ Pharmacovigilance has developed and will continue to develop in response to the special needs

Biography :

Rucha Majmundar Mehta has completed her PhD in Clinical Nutrition from Bombay University and she has completed GCP Audting studies from BARQA, UK. She is the Director of R Q consultants. She is an Independent GCP auditor (Free Lancer) for 10 years. She developed a Clinical Research Site in a privately owned small sized hospital and heading the site till date. She is providing QA consultation and training to various study sites and QA department of Pharmaceutical Companies. She conducts GCP Sessions during Investigators Meetings globally. She has participated in State, National and International Conferences of Clinical Research as a faculty. She is conducting GCP workshops for Clinical Research Professionals for on-going basis and during conferences. She is active member of EFGCP –AWP and RQA.

Top